{"entity":{"type":"insider","cik":"0001944011","url":"/insider/0001944011","json_url":"/insider/0001944011.json","name":"Carter Todd Alfred","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":16,"first":"2023-01-10","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Carter Todd Alfred","source":"filing","n_filings":16,"first_seen":"2023-01-10","last_seen":"2026-02-26"}],"transactions":[{"id":5795791,"accession":"0001104659-26-020176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-020176","line_url":"/filing/0001104659-26-020176#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4174.0,"shares_display":"4,174","price_per_share":3.76,"price_display":"3.76","price_state":"stated","total_value":15694.24,"total_display":"15,694.24","total_whole":"15,694","shares_owned_after":145718.0,"shares_owned_after_display":"145,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":5833318,"accession":"0001104659-26-018130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-018130","line_url":"/filing/0001104659-26-018130#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3301.0,"shares_display":"3,301","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":11355.44,"total_display":"11,355.44","total_whole":"11,355","shares_owned_after":149892.0,"shares_owned_after_display":"149,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":5744180,"accession":"0001104659-26-013408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-013408","line_url":"/filing/0001104659-26-013408#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3525.0,"shares_display":"3,525","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":13571.25,"total_display":"13,571.25","total_whole":"13,571","shares_owned_after":153193.0,"shares_owned_after_display":"153,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":4391878,"accession":"0001104659-25-016522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-016522","line_url":"/filing/0001104659-25-016522#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3305.0,"shares_display":"3,305","price_per_share":4.26,"price_display":"4.26","price_state":"stated","total_value":14079.3,"total_display":"14,079.30","total_whole":"14,079","shares_owned_after":77718.0,"shares_owned_after_display":"77,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-24","scope":"insider"},{"id":4922778,"accession":"0001104659-25-012200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-012200","line_url":"/filing/0001104659-25-012200#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5413.0,"shares_display":"5,413","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":24087.85,"total_display":"24,087.85","total_whole":"24,088","shares_owned_after":81023.0,"shares_owned_after_display":"81,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-12","scope":"insider"},{"id":4051914,"accession":"0001104659-25-003772","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-003772","line_url":"/filing/0001104659-25-003772#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1191.0,"shares_display":"1,191","price_per_share":5.13,"price_display":"5.13","price_state":"stated","total_value":6109.83,"total_display":"6,109.83","total_whole":"6,110","shares_owned_after":86436.0,"shares_owned_after_display":"86,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-15","scope":"insider"},{"id":3231940,"accession":"0001104659-24-026554","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-026554","line_url":"/filing/0001104659-24-026554#line-2","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3365.0,"shares_display":"3,365","price_per_share":7.47,"price_display":"7.47","price_state":"stated","total_value":25136.55,"total_display":"25,136.55","total_whole":"25,137","shares_owned_after":87627.0,"shares_owned_after_display":"87,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-22","scope":"insider"},{"id":3231935,"accession":"0001104659-24-026554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-026554","line_url":"/filing/0001104659-24-026554#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":602.0,"shares_display":"602","price_per_share":7.68,"price_display":"7.68","price_state":"stated","total_value":4623.36,"total_display":"4,623.36","total_whole":"4,623","shares_owned_after":90992.0,"shares_owned_after_display":"90,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider"},{"id":2042962,"accession":"0001104659-24-005244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-005244","line_url":"/filing/0001104659-24-005244#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1266.0,"shares_display":"1,266","price_per_share":7.18,"price_display":"7.18","price_state":"stated","total_value":9089.88,"total_display":"9,089.88","total_whole":"9,090","shares_owned_after":53094.0,"shares_owned_after_display":"53,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-19","scope":"insider"},{"id":8648762,"accession":"0001104659-23-101631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-101631","line_url":"/filing/0001104659-23-101631#line-2","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10500.0,"shares_display":"10,500","price_per_share":8.16,"price_display":"8.16","price_state":"stated","total_value":85680.0,"total_display":"85,680.00","total_whole":"85,680","shares_owned_after":54360.0,"shares_owned_after_display":"54,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":7969233,"accession":"0001104659-23-079686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-079686","line_url":"/filing/0001104659-23-079686#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":10.8,"price_display":"10.80","price_state":"stated","total_value":59400.0,"total_display":"59,400.00","total_whole":"59,400","shares_owned_after":59860.0,"shares_owned_after_display":"59,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-06","filed_date":"2023-07-10","scope":"insider"},{"id":7860612,"accession":"0001104659-23-078152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-078152","line_url":"/filing/0001104659-23-078152#line-2","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":57050.0,"total_display":"57,050.00","total_whole":"57,050","shares_owned_after":65360.0,"shares_owned_after_display":"65,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-30","filed_date":"2023-07-05","scope":"insider"},{"id":7860365,"accession":"0001104659-23-035642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-035642","line_url":"/filing/0001104659-23-035642#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2193.0,"shares_display":"2,193","price_per_share":7.76,"price_display":"7.76","price_state":"stated","total_value":17017.68,"total_display":"17,017.68","total_whole":"17,018","shares_owned_after":65360.0,"shares_owned_after_display":"65,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-22","scope":"insider"},{"id":8752053,"accession":"0001104659-23-024423","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-024423","line_url":"/filing/0001104659-23-024423#line-2","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":738.0,"shares_display":"738","price_per_share":7.45,"price_display":"7.45","price_state":"stated","total_value":5498.1,"total_display":"5,498.10","total_whole":"5,498","shares_owned_after":67553.0,"shares_owned_after_display":"67,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-22","scope":"insider"},{"id":8072539,"accession":"0001104659-23-022430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-022430","line_url":"/filing/0001104659-23-022430#line-1","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":797.0,"shares_display":"797","price_per_share":7.67,"price_display":"7.67","price_state":"stated","total_value":6112.99,"total_display":"6,112.99","total_whole":"6,113","shares_owned_after":34291.0,"shares_owned_after_display":"34,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-15","scope":"insider"},{"id":7860101,"accession":"0001104659-23-005050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-005050","line_url":"/filing/0001104659-23-005050","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1106.0,"shares_display":"1,106","price_per_share":9.848481012658228,"price_display":"9.85","price_state":"stated","total_value":10892.42,"total_display":"10,892.42","total_whole":"10,892","shares_owned_after":35488.0,"shares_owned_after_display":"35,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider","n_lines":2},{"id":8429004,"accession":"0001104659-23-002718","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-002718","line_url":"/filing/0001104659-23-002718#line-2","is_derivative":false,"issuer_cik":"0001640266","issuer_name":"Voyager Therapeutics, Inc.","issuer_ticker":"VYGR","issuer_name_source":null,"issuer_url":"/issuer/0001640266","owner_cik":"0001944011","owner_name":"Carter Todd Alfred","owner_display_name":"Carter Todd Alfred","owner_url":"/insider/0001944011","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":388.0,"shares_display":"388","price_per_share":6.41,"price_display":"6.41","price_state":"stated","total_value":2487.08,"total_display":"2,487.08","total_whole":"2,487","shares_owned_after":36194.0,"shares_owned_after_display":"36,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001640266","name":"Voyager Therapeutics, Inc.","url":"/issuer/0001640266","role":"Officer (Chief Scientific Officer)","n_filings":16,"first_seen":"2023-01-10","last_seen":"2026-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001944011","retrieved_at":"2026-08-26T12:55:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}